Weekly healthcare intelligenceRegulation · Enforcement · Government payersAll editions →

Medicare & Medicaid Sweep · November 8, 2026

The leading stories for your work. Choose a topic to focus the front page.

Published November 8, 2026 · Reporting window November 1–7, 2026, Pacific. Later developments are labelled. Source coverage is incomplete; the complete reports describe the limitations.

Showing 15 of 36 articles and reminders.

Illustrative artwork
Billing & paymentMedicare & Medicaid SweepNew in this edition

CMS issues CY 2027 Physician Fee Schedule final rule (CMS-1848-F): conversion factors fall, same-day E/M and 0-day global payment cut, new 340B Part D claims repository duty

On November 4, 2026, CMS released the CY 2027 Physician Fee Schedule (PFS) final rule, effective January 1, 2027; the rule was published in the Federal Register on November 9, 2026. CMS projects the qualifying alternative payment model (APM) conversion factor at $32.95 and the non-qualifying APM conversion factor at $32.63, decreases of 1.83% and 2.31% from CY 2026, after the one-year 2.50% CY 2026 statutory increase lapses. CMS finalized a payment reduction when a separately identifiable office/outpatient evaluation and management (E/M) visit is furnished on the same day as a 0-day global procedure, paying the most expensive service at 100% and the others at 80%, narrower than proposed. The proposal covered a visit furnished by the same physician (or a physician in the same practice) on the same day as a 0-, 10- or 90-day global procedure; the fact sheet says CMS made two significant modifications to it and does not restate the same-physician condition for the final policy. G2211 becomes modifier B1 (16% increase to the E/M code), and a voluntary B2 modifier (32%) is created for practitioners in a Shared Savings Program Accountable Care Organization (ACO) and Participant Providers in a Long-term Enhanced ACO Design (LEAD) Model ACO. The fact sheet says providers and suppliers that are 340B covered entities must submit claim data for covered Part D drugs billed to Medicare Part D and dispensed by the entity or its contractors (such as contract pharmacies) under a 340B discount to the Medicare Part D Claims Data 340B Repository, beginning with claims with dates of service on or after January 1, 2027, with the first quarterly submission deadline moved to September 30, 2027.

High priority · Nov 8, 2026 editionRead story →

Illustrative artwork
Billing & paymentMedicare & Medicaid SweepNew in this edition

Medicare to pay ASP minus 28 percent for separately payable 340B-acquired drugs at non-exempt hospitals from January 1, 2027 (pass-through drugs, vaccines and non-opioid pain relief drugs excluded); every separately paid OPPS drug line must carry modifier JG, TB or ND

Based on its 2026 drug acquisition cost survey, CMS finalized payment for separately payable 340B-acquired drugs, other than drugs with pass-through payment status, vaccines and non-opioid pain relief drugs with status indicator K1, at average sales price (ASP) minus 28 percent for CY 2027 and subsequent years, choosing its alternative proposal over the proposed ASP minus 33.4 percent; separately payable non-340B drugs are generally still paid at ASP plus 6 percent. The cut is budget neutral within the Hospital Outpatient Prospective Payment System (OPPS), raising non-drug payment rates by an estimated 7.50 percent, and also applies (not budget neutral) to 340B drugs furnished in non-excepted off-campus provider-based departments (PBDs). Rural sole community hospitals (SCHs), children's hospitals and prospective payment system (PPS)-exempt cancer hospitals are exempt, and no add-on payment was adopted. From January 1, 2027, every separately paid OPPS drug claim line must carry JG (a separately payable drug acquired under the 340B Program at a hospital subject to the cut; it triggers the reduction), TB (informational; the rule's summary lists it for 340B-acquired drugs at exempt hospitals and for pass-through and non-opioid pain relief drugs, while the detailed discussion describes TB as marking drugs bought with a 340B discount) or ND (not acquired under 340B; the proposal used placeholder XX). How a pass-through or non-opioid pain relief drug bought without a 340B discount is reported should be confirmed against the rule's final modifier table and CMS claims instructions. CMS estimates OPPS 340B drug payments fall about $4.65 billion and total 340B drug spending about $5.45 billion in CY 2027.

High priority · Nov 8, 2026 editionRead story →

Illustrative artwork
Billing & paymentMedicare & Medicaid SweepNew in this edition

CMS seeks emergency clearance to expand the home health Review Choice Demonstration to California

On November 2, CMS published an emergency Paperwork Reduction Act notice for a revision of the CMS-10599 information collection for the Review Choice Demonstration for Home Health Services, stating that approval is essential so the demonstration is expanded to California within the specified timeframe. The notice says the demonstration already operates in Illinois, Ohio, North Carolina, Florida and Texas, and that providers in demonstration states may choose 100 percent pre-claim review or 100 percent post-payment review until they reach a target affirmation or claim approval rate. A November 4 correction removed one sentence from the notice and states that the option referenced in that language is no longer part of the information collection request. Comments are due November 16, 2026, and the correction states the comment period is unchanged.

Medium priority · Nov 8, 2026 editionRead story →

Illustrative artwork
Medi-Cal & Medicaid policyMedicare & Medicaid SweepNew in this edition

Medi-Cal: members with Unsatisfactory Immigration Status move from managed care to fee-for-service on January 1, 2027; clinic billing rules posted

On November 6, 2026 the Medi-Cal provider site published billing and reimbursement policy for Federally Qualified Health Centers and Rural Health Clinics serving members with Unsatisfactory Immigration Status, who move from Medi-Cal managed care plans to the fee-for-service delivery system effective January 1, 2027. The notice says the transition does not change a member's eligibility, and that members keep full-scope coverage through state funding if they renew on time. From January 1, 2027 these clinics must submit claims directly to the Medi-Cal fiscal intermediary (the notice says there is no change in how they submit dental claims) and will receive the Prospective Payment System rate for eligible visits; claims for a managed care plan differential (wrap) rate for services on or after that date will be denied. Clinics already enrolled in Medi-Cal need no additional enrollment. In the same week the site published a notice of change on Treatment Authorization Requests for these members (November 2) and a fee-for-service provider toolkit for the transition (November 6).

Medium priority · Nov 8, 2026 editionRead story →

Illustrative artwork
Billing & paymentMedicare & Medicaid SweepNew in this edition

CMS finalizes CY 2027 OPPS update: 2.3 percent increase factor, $99.970 conversion factor, $7,150 outlier threshold

CMS published the CY 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) final rule with comment period on November 6, 2026, effective January 1, 2027. The outpatient department (OPD) fee schedule increase factor is 2.3 percent (3.2 percent market basket less a 0.9 percentage point productivity adjustment); the proposal had been 2.4 percent with a 0.8 point adjustment, and the rule says the change reflects more recent data. The final conversion factor is $99.970; hospitals that fail Hospital Outpatient Quality Reporting (OQR) requirements get a reporting ratio of 0.9804 and a reduced conversion factor of $98.011. The outlier fixed-dollar threshold rises from $6,225 (CY 2026) to $7,150 with the 1.75 multiplier unchanged. CMS estimates total CY 2027 OPPS payments of about $114.4 billion and a net 1.7 percent increase from all finalized policies, with urban hospitals up 2.0 percent, rural hospitals up 5.6 percent, major teaching hospitals down 2.0 percent and government-owned hospitals down 1.1 percent.

Medium priority · Nov 8, 2026 editionRead story →

More in this edition

Read all 36 articles and reminders →

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies